MAG-O3® Vision Complex
Natural health product licensed in Canada
- Other names
- MAG-O3® Macular Shield, MAG-O3® Ocular Omega Complex, MAG-O3® Vision Defense
- Licence holder
- High Five Health Group Inc.
- NPN or DIN-HM
- 80150042
- Status
- Active licence
- Licence date
- 28 July 2026
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3'-Dihydroxy-4,4'-diketo-bêta-carotène Source : Haematococcus pluvialis - whole | 4 mg | Not calculated |
| (3R,3'R)-bêta,bêta-Carotène-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 2 mg | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 32 mg Eicosapentaenoic acid | 300 mg | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 32 mg Eicosapentaenoic acid | 300 mg | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 32 mg Eicosapentaenoic acid | 300 mg | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 165 mg Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 165 mg Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 165 mg Docosahexaenoic acid | Not specified | Not calculated |
Non-medicinal ingredients
Glycérine, Lécithine, Eau purifiée, Mélange de concentré de tocophérols (type alpha inférieur), Poudre de caroube, Gélatine, Huile essentielle de citron, Cire d'abeille jaune
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support/maintain brain function. Helps support/maintain cognitive health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Source of omega-3 fatty acids for the maintenance of good health. Helps to improve macular pigment optical density. Helps to maintain eyesight/support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of (an) antioxidant(s)/Provides (an) antioxidant(s).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80150042
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.